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Clinical Case Report
ABSTRACT
Introduction: Acute liver failure (ALF) due to diffuse infiltrating solid malignancy without any focal lesions on radiographic 
imaging is rare. Case report: A 70-year-old man was admitted due to mental confusion, abdominal pain, and ALF. Three 
years before, he had undergone a left nephrectomy for urothelial carcinoma followed by adjuvant chemotherapy. The 
abdominal computed tomography (CT) showed hepatomegaly and ascites. Ascitic fluid had transudate characteristics, 
with no malignant cells. Percutaneous liver biopsy (LB) showed diffuse liver infiltration of metastatic urothelial carcinoma. 
The patient rapidly deteriorated and died in a week due to ALF. Discussion: History of solid cancer and hepatomegaly 
and/or liver failure without other obvious explanation should encourage to perform LB. Conclusion: LB is warranted to 
avoid misdiagnosis, prolonged hospital stays, and delay in palliative care. 
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INTRODUCTION
Acute liver failure (ALF) is a life-threatening critical 
illness that occurs most often in patients with no 
previous liver disease history.1 Solid cancers commonly 
present with a primary lesion and metastasis to one 
or more organs easily detected by imaging, including 
computed tomography (CT) and magnetic resonance 
imaging (MRI). However, despite being rare, ALF due 
to infiltrating malignancy without any focal lesions on 
imaging can occur and is associated with high mortality. 
Neoplasms, including the gastrointestinal tract, breast, 
urothelial, lung, and nasopharynx cancers, as well as 
lymphomas, leukemias, and malignant histiocytosis, 
are the most involved.2,3 ALF results from diffuse 
sinusoidal infiltration, portal vein thrombosis, hepatic 
ischemia, and necrosis.2 In this report, we describe a 
case of a patient with ALF due to infiltrating urothelial 
malignancy. We highlight the importance of a high 
level of suspicion in preventing clinical hesitation to liver 
biopsy (LB), misdiagnosis, and delay in palliative care.
CASE REPORT
A 70-year-old man was admitted with a 3-day 
history of mental confusion, diffuse abdominal pain, 
nausea, and lethargy, which gradually worsened. 
No new medication was introduced in the previous 
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days. Neither alcohol nor illicit drug consumption was 
reported. His medical history included a nephrectomy, 
followed by adjuvant chemotherapy (gemcitabine and 
carboplatin) to treat urothelial carcinoma, three years 
ago. On the physical examination, the patient was icteric 
and drowsy, with mild alteration of the sensorium. He 
had asterixis and grade II encephalopathy. His body 
temperature was 36 °C, pulse rate was 88 bpm, 
respiratory rate was 22/min, and blood pressure 
was 108/55 mmHg. Lung and heart examination 
was unremarkable, and moderate hepatomegaly, 
and ascites were detected on abdominal palpation. 
Blood examination showed in Table 1 was consistent 
with liver failure. Serology tests for viral hepatitis 
and HIV were negative, and antinuclear and anti-
smooth muscle antibodies were undetectable. Head 
CT showed no intracranial space-occupying lesions. 
High-resolution abdominal CT showed hepatomegaly 
with diffuse inhomogeneous parenchyma, extensive 
periaortic lymph nodes involvement, ascites, with no 
genitourinary system lesions or peritoneal implants 
(Figure 1). Abdominal paracentesis was performed, 
draining an ascitic fluid with transudate characteristics 
and negative results for bacterial culture neither 
malignant cells. The patient underwent percutaneous 
LB showing diffuse liver infiltration by metastatic 
carcinoma (Figure 2) with immunohistochemical 
profile positive for p63, CK20, CK7, and negative 
for CD10 (Figure 3), suggesting urothelial origin. No 
complications related to LB occurred. Palliative care 
was promptly and properly initiated. Besides this, the 
patient rapidly deteriorated and died in a week due 
to the onset of ALF.
DISCUSSION
Solid cancers mainly involved in the hepatic 
infiltrative metastatic pattern are lung, breast, renal and 
urothelial cancers, whereas there are anecdotal cases 
involving prostate, melanoma and neuroblastoma. 
Infiltrative liver disease caused by solid cancer 
metastases is a rare cause of ALF4 and usually presents 
with unspecific findings such as hepatomegaly, 
transudative ascites with the absence of malignant cells, 
high levels of aminotransferases, conjugated bilirubin 
and LDH. Despite widely reported,5-9 it is frequently 
diagnosed post-mortem as the first case due to diffuse 
metastases of urothelial carcinoma reported in 1996.5 
Conventional imaging including both CT and MRI have 
been reported to show low performance in detecting 
metastatic infiltrative liver disease, probably due to the 
micro-invasion histological pattern.7,10 In cases with 
unspecific clinical, laboratory and imaging findings, 
the percutaneous/trans jugular LB, is the most accurate 
tool to obtain a proper diagnosis in patients with ALF 
of unknown cause. Although the risk of bleeding due 
to coagulation abnormalities and low platelet count 
should always be considered, LB seems to be one of the 
best prognostic tools in internal medicine, especially 
in older patients without a diagnosis, who would not 
be candidates for transplantation. Finally, given that 
ALF due to malignant infiltration of the liver could be 
seen both in patients with or without a history of solid 
cancer and given the poor prognosis, LB may expedite 
palliative care.
Table 1. Laboratory work up
Exam Result RR Exam Result RR
Hemoglobin 10.7 11.5–15.5 g/dL ALT 1154 <35 U/L
Leukocytes 7800 4500–11000 /µL Gamma-GT 204 <38 U/L
Platelet 177 150–450 × 103/µL AP 192 30–120 U/L
Urea 39 17–43 mg/dL LDH 568 <247 U/L
Creatinine 0.72 0.51–0.95 mg/dL INR 1.98 0.8–1.2
TB 8.4 0.3–1.0 mg/dL Ferritin 407 24–336 ng/mL
DB 5.6 0.1–0.3 mg/dL Ceruloplasmin 35 14–40 mg/dL
AST 3190 <35 U/L 24-h urine copper 22 20–50 µg
ALT = alanine transaminase; AP= alkaline phosphatase; AST= aspartate transaminase; DB= direct bilirubin; Gamma GT= 
gamma glutamyl transferase; INR= international normalized ratio; LDH= lactate dehydrogenase, RR=reference range; TB= 
total bilirubin.
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Figure 1. A and B - High-resolution abdominal CT showing hepatomegaly with diffuse inhomogeneous parenchyma, 
extensive periaortic lymph nodes involvement, and ascites.
Figure 2. Photomicrograph of the liver biopsy showing diffuse liver infiltration by metastatic urothelial carcinoma. 
(H&E; 40x).
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Figure 3. Photomicrograph of the liver biopsy showing positive reaction for p63, CK7, CK20 and negative reaction 
for CD10 in the malignant cells. (40x).
CONCLUSION
History of solid cancer and hepatomegaly and/
or liver failure without other obvious explanations 
should encourage to perform LB. LB is warranted to 
avoid misdiagnosis, prolonged hospital stays and delay 
in palliative care. The main key-points highlighted by 
this case are the following: (1) radiographically occult 
liver infiltration caused by solid metastatic cancer 
should always be considered as a cause of ALF; (2) 
conventional imaging examinations poorly detect 
diffuse metastatic infiltrative disease; (3) the LB may 
shorten the delay of the diagnosis and palliative care.
REFERENCES
1. Bernal W, Wendon J. Acute liver failure. N Engl J Med. 
2013;369(26):2525-34. http://dx.doi.org/10.1056/
NEJMra1208937. PMid:24369077.
2. van Marcke C, Coulier B, Gielen I, Maldague P. Acute 
liver failure secondary to metastatic liver infiltration: case 
report and review of the literature. Acta Gastroenterol 
Belg. 2013;76(4):436-8. PMid:24592549.
3. Campos FPF, Felipe-Silva A, Zerbini MCN. Anaplastic 
large cell lymphoma ALK-negative clinically mimicking 
alcoholic hepatitis - A review. Autops Case Rep. 
2013;3(3):11-9. http://dx.doi.org/10.4322/acr.2013.023. 
PMid:31528614.
4. Athanasakis E, Mouloudi E, Prinianakis G, Kostaki M, Tzardi 
M, Georgopoulos D. Metastatic liver disease and fulminant 
hepatic failure: presentation of a case and review of the 
literature. Eur J Gastroenterol Hepatol. 2003;15(11):1235-
40. http://dx.doi.org/10.1097/00042737-200311000-
00014. PMid:14560159.
5. Alcalde M, Garcia-Diaz M, Pecellin J, et al. Acute 
liver failure due to diffuse intrasinusoidal metastases 
of urothelial carcinoma. Acta Gastroenterol Belg. 
1996;59(2):163-5. PMid:8903067.
6. Alexopoulou A, Koskinas J, Deutsch M, Delladetsima 
J, Kountouras D, Dourakis SP. Acute liver failure as 
the initial manifestation of hepatic infiltration by 
a solid tumor: report of 5 cases and review of the 
literature. Tumori. 2006;92(4):354-7. http://dx.doi.
org/10.1177/030089160609200417. PMid:17036530.
Tosatto V, Pimentel JC, Cruz C, Almeida A, Boattini M
5-5Autops Case Rep (São Paulo). 2021;11:e2021256
7. Varghese J, Jayanthi V, Patra S, Rela M. Massive infiltration 
of liver by metastatic adenocarcinoma: a rare cause of acute 
hepatic failure. J Clin Exp Hepatol. 2012;2(3):286-8. http://
dx.doi.org/10.1016/j.jceh.2012.06.002. PMid:25755446.
8. Simone C, Murphy M, Shifrin R, Zuluaga Toro T, Reisman 
D. Rapid liver enlargement and hepatic failure secondary 
to radiographic occult tumor invasion: two case reports 
and review of the literature. J Med Case Reports. 
2012;6(1):402. http://dx.doi.org/10.1186/1752-1947-
6-402. PMid:23181360.
9. Lanzas Prieto JM, Alonso de la Campa JM, Guate 
Ortiz JL, et al. Insuficiencia hepática fulminante por 
metástasis hepática intrasinusoidal difusa en un paciente 
con carcinoma transicional de vejiga. Arch Esp Urol. 
2002;55(5):547-51. PMid:12174423.
10. Nascimento AB, Mitchell DG, Rubin R, Weaver E. Sinusoidal 
spread of liver metastases from renal cell carcinoma: 
simulation of diffuse liver disease on MR imaging. Abdom 
Imaging. 2002;27(2):196-8. http://dx.doi.org/10.1007/
s00261-001-0065-0. PMid:11847581.
This study was carried out at the Centro Hospitalar Universitário de Lisboa Central. Lisbon, Portugal.
Author’s contributions: All the authors collectively took care of the patient. Valentina Tosatto, Matteo Boattini 
and João Cabral Pimentel wrote the paper; while Cristiano Cruz and André Almeida review it.
Ethics statement: Informed consent authorizing data publication was obtained from patient family members. 
Ethical approval for reporting individual cases was not required by our Institution Ethics Committee.
Conflict of interest: The authors have no conflict of interest to declare.
Financial support: The authors declare that no financial support was received.
Submitted on: December 15th, 2020 
Accepted on: January 31st, 2021
Correspondence 
Valentina Tosatto 
Hospital de Santa Marta, Department of Internal Medicine 4 
Rua de Santa Marta 50, 1169-024, Lisbon, Portugal 
Phone: +351 21 359 4237 
valentina.tosatto@gmail.com
